Craft
  • Home
  •  / Rapid Micro Biosystems
Rapid Micro Biosystems

Rapid Micro Biosystems

Revenue

$23.2 M

FY, 2021

Market Capitalization

$144.3 M

2022-09-20

Rapid Micro Biosystems Summary

Company summary

Overview
Rapid Micro Biosystems is a company providing pharmaceutical quality control for the detection of microbial contamination in the manufacture of pharmaceuticals, biologics, cell and gene therapies, vaccines, medical devices, and personal care products. It offers the Growth Direct platform, a non-destructive detection method with blue LED light technology.
Type
Public
Founded
2006
HQ
Lowell, MA, US | view all locations
Website
https://www.rapidmicrobio.com/
Cybersecurity rating
Sectors

Key people

  • Robert Spignesi

    Robert Spignesi, President and Chief Executive Officer, Director

  • Sean Wirtjes

    Sean Wirtjes, Chief Financial Officer

  • John Wilson

    John Wilson, Chief Operating Officer

  • Andy Keys

    Andy Keys, Chief Commercial Officer

LocationsView all

2 locations detected

  • Lowell, MA HQ

    United States

    1001 Pawtucket Blvd West, Suite 280

  • Freising, BY

    Germany

    Lise-Meitner-Straße 30

Rapid Micro Biosystems Financials

Summary financials

Revenue (Q2, 2022)
$3.9M
Net income (Q2, 2022)
($13.1M)
Cash (Q2, 2022)
$49.7M
EBIT (Q2, 2022)
($14.1M)
Enterprise value
$95.3M

Footer menu